[go: up one dir, main page]

NO974075D0 - Fremgangsmåte og anvendelse av vannbasert topisk krem som inneholder nitroglycerin - Google Patents

Fremgangsmåte og anvendelse av vannbasert topisk krem som inneholder nitroglycerin

Info

Publication number
NO974075D0
NO974075D0 NO974075A NO974075A NO974075D0 NO 974075 D0 NO974075 D0 NO 974075D0 NO 974075 A NO974075 A NO 974075A NO 974075 A NO974075 A NO 974075A NO 974075 D0 NO974075 D0 NO 974075D0
Authority
NO
Norway
Prior art keywords
water
application
cream containing
topical cream
based topical
Prior art date
Application number
NO974075A
Other languages
English (en)
Other versions
NO974075L (no
Inventor
Michael P Allen
Original Assignee
Int Medical Innovations Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Medical Innovations Inc filed Critical Int Medical Innovations Inc
Publication of NO974075D0 publication Critical patent/NO974075D0/no
Publication of NO974075L publication Critical patent/NO974075L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO974075A 1995-03-06 1997-09-04 Fremgangsmåte og anvendelse av vannbasert topisk krem som inneholder nitroglycerin NO974075L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39887295A 1995-03-06 1995-03-06
US08/594,304 US5698589A (en) 1993-06-01 1996-01-30 Water-based topical cream containing nitroglycerin and method of preparation and use thereof
PCT/US1996/002989 WO1996027372A1 (en) 1995-03-06 1996-03-05 Water-based topical cream containing nitroglycerin; method of preparation and use thereof

Publications (2)

Publication Number Publication Date
NO974075D0 true NO974075D0 (no) 1997-09-04
NO974075L NO974075L (no) 1997-10-27

Family

ID=27016409

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974075A NO974075L (no) 1995-03-06 1997-09-04 Fremgangsmåte og anvendelse av vannbasert topisk krem som inneholder nitroglycerin

Country Status (21)

Country Link
US (1) US5698589A (no)
EP (1) EP0814800B1 (no)
JP (1) JPH11501629A (no)
KR (1) KR19980702766A (no)
CN (1) CN1139380C (no)
AP (1) AP691A (no)
AT (1) ATE209895T1 (no)
AU (1) AU701328B2 (no)
BR (1) BR9607974A (no)
CZ (1) CZ281897A3 (no)
DE (1) DE69617654T2 (no)
EA (1) EA000566B1 (no)
HU (1) HUP9801234A3 (no)
NO (1) NO974075L (no)
NZ (1) NZ305095A (no)
OA (1) OA10504A (no)
PL (1) PL322110A1 (no)
SI (1) SI9620038A (no)
SK (1) SK117597A3 (no)
TR (1) TR199700909T1 (no)
WO (1) WO1996027372A1 (no)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
USRE37234E1 (en) * 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US5958926A (en) 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
GB2325855B (en) * 1997-06-04 2001-08-29 Healthscene Ltd Preparation for topical application to the male sexual organ
EP1535611A3 (en) * 1997-06-23 2009-09-16 Strakan International Limited Microdose therapy of vascular conditions by no donors
ES2257813T3 (es) * 1997-06-23 2006-08-01 Cellegy Pharmaceuticals, Inc Terapia de microdosis de condiciones vasculares mediante donadores de no.
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US6593369B2 (en) 1997-10-20 2003-07-15 Vivus, Inc. Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US20040014761A1 (en) * 1997-10-28 2004-01-22 Place Virgil A. Treatment of female sexual dysfunction with phosphodiesterase inhibitors
US20050070516A1 (en) * 1997-10-28 2005-03-31 Vivus Inc. As-needed administration of an androgenic agent to enhance female desire and responsiveness
JP2001520999A (ja) 1997-10-28 2001-11-06 アシビ， エルエルシー 女性の性的機能不全の処置
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
GB9802078D0 (en) * 1998-01-30 1998-03-25 Futura Medical Limited Preparation for treatment of erectile dysfunction
WO1999062533A1 (en) * 1998-06-04 1999-12-09 Jedco Products, Llc Preparation for topical application to the male sexual organ
US7087240B1 (en) 1998-06-25 2006-08-08 Lavipharm Laboratories Inc. Device and method for the treatment of erectile dysfunction
GB9818524D0 (en) * 1998-08-25 1998-10-21 Futura Medical Limited Inorgasmia treatment
IT1303793B1 (it) * 1998-11-27 2001-02-23 Promefarm S R L "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
WO2001085013A2 (en) 2000-05-09 2001-11-15 Nitromed, Inc. Infrared thermography and methods of use
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
ES2291333T3 (es) 2000-06-27 2008-03-01 Qualilife Pharmaceuticals Inc. Composiciones y metodos para el tratamiento de la respuesta sexual de las mujeres.
HUP0002628A2 (en) * 2000-07-14 2002-06-29 Keri Pharma Kft Pharmaceutical combinations for treating diabetes
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
CN1473047A (zh) * 2000-08-30 2004-02-04 ������ҩ�����޹�˾ 治疗男性勃起功能障碍和增强性冲动的方法
CA2440141A1 (en) * 2001-03-06 2002-09-12 Cellegy Pharmaceuticals, Inc. Compounds and methods for the treatment of urogenital disorders
JP2003040763A (ja) * 2001-05-23 2003-02-13 Taisho Pharmaceut Co Ltd 多価アルコール含有軟膏剤基剤
SE0103528D0 (sv) * 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
MXPA04007828A (es) * 2002-02-15 2004-10-15 Nexmed Holdings Inc Composicion de prostaglandina para eltratamiento de la disfuncion erectil.
HU230920B1 (hu) * 2002-03-15 2019-03-28 Besins Healthcare Luxembourg Sarl Depresszió kezelésére szolgáló androgén gyógyászati készítmények
BR0308584A (pt) * 2002-03-15 2005-02-22 Unimed Pharmaceuticals Inc Composição farmacêutica androgênica e método para tratamento de depressão
US7763256B2 (en) * 2002-12-23 2010-07-27 William Marsh Rice University Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
US8012472B2 (en) * 2002-12-23 2011-09-06 William Marsh Rice University Compositions and methods for suppressing fibrocytes
CA2509241C (en) * 2002-12-23 2013-07-30 William Marsh Rice University Use of serum amyloid p (sap) and related compositions for the suppression of fibrosis-related diseases
US20100297074A1 (en) * 2002-12-23 2010-11-25 Richard Hans Gomer Wound healing compositions, systems, and methods
US20050031699A1 (en) 2003-06-26 2005-02-10 L'oreal Porous particles loaded with cosmetically or pharmaceutically active compounds
GB0417675D0 (en) * 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
WO2006055726A2 (en) * 2004-11-17 2006-05-26 Lindsey Berkson Composition and method for facilitating the healing of non-healing and slow-healing wounds and ulcerations
US20060127483A1 (en) * 2004-12-10 2006-06-15 Alan Drizen Topical drug delivery system
GB0602224D0 (en) 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
WO2008070117A1 (en) * 2006-12-04 2008-06-12 Promedior, Inc. Conjoint therapy for treating fibrotic diseases
US8497243B2 (en) * 2007-07-06 2013-07-30 Promedior, Inc. Methods and compositions useful in the treatment of mucositis
US9884899B2 (en) 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
DE202008007318U1 (de) * 2008-03-14 2008-07-31 G. Pohl-Boskamp Gmbh & Co. Kg Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat
US20100263675A1 (en) * 2009-04-21 2010-10-21 Ansell Healthcare Products Llc Condom with Localized Active Agent
US20100035929A1 (en) * 2008-06-09 2010-02-11 Lindsley Craig W Unnatural dispyrin analogues, preparation and uses thereof
WO2010011650A1 (en) * 2008-07-21 2010-01-28 Imi International Medical Innovations (D/B/A Procris Pharmaceuticals) Stable water-based topical pharmaceutical creams and methods of making and using same
WO2010057117A2 (en) * 2008-11-14 2010-05-20 Helm Pharmaceuticals, Inc. Topical transdermal drug delivery compositions
PT2405929T (pt) * 2009-03-11 2018-07-23 Promedior Inc Métodos de tratamento para distúrbios autoimunes
DK2405928T3 (en) * 2009-03-11 2017-01-30 Promedior Inc Treatment and diagnosis procedure for hypersensitive diseases
UA110323C2 (en) * 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
JP5822826B2 (ja) * 2009-06-17 2015-11-24 プロメディオール， インコーポレイテッド Ｓａｐ変異体及びその使用
WO2011057386A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd. Composition and prophylactic device for enhancing sexual performance or pleasure
WO2012016690A1 (en) 2010-08-03 2012-02-09 G. Pohl-Boskamp Gmbh & Co. Kg Use of glyceryl trinitrate for treating hematomas
WO2012113563A1 (en) 2011-02-25 2012-08-30 G. Pohl-Boskamp Gmbh & Co. Kg Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
EP2668947B1 (en) 2012-05-31 2016-11-30 G. Pohl-Boskamp GmbH & Co. KG Induction of arteriogenesis with a nitric oxide-donor such as nitroglycerin
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
TW201943428A (zh) 2018-04-16 2019-11-16 大陸商上海岸闊醫藥科技有限公司 預防或治療腫瘤療法副作用的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4336243A (en) * 1980-08-11 1982-06-22 G. D. Searle & Co. Transdermal nitroglycerin pad
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5001151A (en) * 1987-08-11 1991-03-19 Fujisawa Usa, Inc. Aqueous nitroglycerin injection and manufacturing process
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof

Also Published As

Publication number Publication date
AU701328B2 (en) 1999-01-28
NO974075L (no) 1997-10-27
EA000566B1 (ru) 1999-12-29
JPH11501629A (ja) 1999-02-09
AP691A (en) 1998-10-12
HUP9801234A2 (hu) 1999-01-28
CN1177294A (zh) 1998-03-25
ATE209895T1 (de) 2001-12-15
EP0814800B1 (en) 2001-12-05
AU5302596A (en) 1996-09-23
TR199700909T1 (xx) 1998-02-21
HK1005359A1 (en) 1999-01-08
WO1996027372A1 (en) 1996-09-12
BR9607974A (pt) 1998-01-13
KR19980702766A (ko) 1998-08-05
SK117597A3 (en) 1998-01-14
AP9701068A0 (en) 1997-10-31
NZ305095A (en) 2005-05-27
CN1139380C (zh) 2004-02-25
PL322110A1 (en) 1998-01-05
EP0814800A4 (en) 1998-07-01
DE69617654D1 (de) 2002-01-17
SI9620038A (sl) 1998-04-30
EP0814800A1 (en) 1998-01-07
OA10504A (en) 2002-04-24
HUP9801234A3 (en) 2000-07-28
EA199700213A1 (ru) 1998-02-26
CZ281897A3 (en) 1997-12-17
US5698589A (en) 1997-12-16
DE69617654T2 (de) 2002-08-08

Similar Documents

Publication Publication Date Title
NO974075D0 (no) Fremgangsmåte og anvendelse av vannbasert topisk krem som inneholder nitroglycerin
HUP9801175A3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
FI964028L (fi) Uusi farmaseuttinen formulaatio ja menetelmä
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
NO962919D0 (no) Fremgangsmåte og anordning for impulskjöp av pakkede informasjonstjenester
PL300335A1 (en) Pharmaceutical agent, novel derivatives of 4-thiazinylinone and method of obtaining such novel derivatives
DE69631056D1 (de) Zusammensetzungen von süssigkeiten
NO20016198D0 (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
NO974685D0 (no) Acetamidderivater, fremgangsmåte for fremstilling av disse, og farmasöytisk preparat inneholdende disse
IS4536A (is) Ný taxóíð, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þau
DK0790595T3 (da) Anordning og fremgangsmåde til datatransformation
NO974365D0 (no) Fremgangsmåte og krystallformer av 2-metyl-thieno-benzodiazepin
IS4635A (is) 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær
AU6676596A (en) Memory element and method of operation thereof
NO980055D0 (no) Antisoppmiddel, forbindelse derfor og fremgangsmåte for fremstilling derav
DK0702344T3 (da) Etiketkontinuum og fremgangsmåde til fremstilling deraf
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
DK0596122T3 (da) Fremgangsmåde til omvikling og omviklet genstand
NO932282L (no) Oljeaktig preparat og fremgangsmaate for fremstilling av dette
AU6835996A (en) Pyridinium derivatives and pharmaceutical compositions containing them
PT100604A (pt) Novos 4(5)-imidazois inibidores selectivos da aromatase
DK0828733T3 (da) Benzopyraner og farmaceutiske præparater indeholdende dem
DE69629359D1 (de) Trimebutinhaltiges arzneimittel und verfahren
NO954574L (no) Fremgangsmåte til innfrysing av varer og anordning for utförelse av samme
NO985623L (no) Tynnfilmtransistor og fremgangsmÕte for fremstilling av samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application